• Categories: ,

    News from the ESTRO 2021 congress: EORTC-ESTRO RADiation Infrastructure for Europe (E2-RADIatE) OligoCare trial assesses real-world patterns of practice of radical radiotherapy for oligometastatic disease

    28 Aug 2021

  • Categories: ,

    News from the ESTRO 2021 congress: Denis Lacombe, awarded honorary membership of ESTRO, emphasises the importance of radiation oncology in multidisciplinary research

    28 Aug 2021

  • prostate cancer trial banner
    Categories: ,

    Combined hormone/radiotherapy treatment improves event-free and disease-free survival in patients with localised intermediate risk prostate cancer; long-term results from EORTC Trial 22991

    30 Jul 2021

  • Categories: ,

    EORTC 1634-Brain Tumour Group trial in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I) receives support from Gateway for Cancer Research℠

    27 Jul 2021

  • Melanoma
    Categories: , ,

    PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients

    29 Jun 2021

  • Logos - EHSG final statement
    Categories:

    European Health Stakeholder Group Statement on the UK data protection regime

    25 Jun 2021

  • EORTC new governance & new president-elect
    Categories:

    EORTC announces new governance with new Board of Directors and President-Elect

    21 Jun 2021

  • ASCO 2021 - banner
    Categories:

    EORTC in the spotlight at ASCO 2021

    9 Jun 2021